Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $46.93 USD
Change Today -0.36 / -0.76%
Volume 193.2K
ALR On Other Exchanges
As of 12:24 PM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

alere inc (ALR) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/13/15 - $55.99
52 Week Low
10/15/14 - $35.62
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ALERE INC (ALR)

alere inc (ALR) Related Businessweek News

View More BusinessWeek News

alere inc (ALR) Details

Alere Inc. provides point-of-care diagnostics and services for infectious disease, cardiometabolic disease, and toxicology in the United States and internationally. The company operates through Professional Diagnostics and Consumer Diagnostics segments. Its cardiometabolic products and services include tests to assist in the diagnosis and management of various cardiometabolic factors and conditions, including cardiac markers, glucose and HbA1C, cholesterol levels, blood gases, and home monitoring for VAD and oral anticoagulation. These meters and tests are used in hospital urgent care, laboratory, doctor’s office, or at home. The company’s infectious disease products and services comprise tests to assist in the diagnosis and management of infectious diseases, such as HIV, malaria, syphilis, E. coli, and influenza. The infectious disease diagnostic tests and monitoring devices provide results for approximately 75 types of infectious diseases, including those caused by bacteria, viruses, fungi, or parasites. Its drug and alcohol testing portfolio includes rapid analyzer-based tests, visual-read screening devices, laboratory tests, and immunoassay reagents. The company’s toxicology products are used in hospitals, clinics, physician offices, criminal justice systems, workplace, rehabilitation, occupational health clinics, home testing, and other. Alere Inc. also delivers services and solutions across various environments, including clinical immunology, women's health, and oncology. It markets its professional diagnostic products through its sales force and distribution networks; and First Check consumer drug testing products through retail drug stores, drug wholesalers, groceries, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. in July 2010. Alere Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

9,800 Employees
Last Reported Date: 05/28/15
Founded in 1981

alere inc (ALR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $882.1K
Global President of Toxicology
Total Annual Compensation: $650.0K
Global President of Cardiometabolic Business ...
Total Annual Compensation: $548.1K
Global President of Infectious Disease Busine...
Total Annual Compensation: $486.3K
Compensation as of Fiscal Year 2014.

alere inc (ALR) Key Developments

Alere Inc. Announces Resignation of David Teitel as Senior Vice President of Finance and Executive Officer

On September 30, 2015, David Teitel, Alere Inc.'s Senior Vice President of Finance and a named executive officer, resigned from his employment with the company.

Alere Inc. Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-16-2015 02:15 PM

Alere Inc. Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-16-2015 02:15 PM. Venue: The Grand Hyatt New York, 109 East 42nd Street, New York, New York, United States. Speakers: James F. Hinrichs, Chief Financial Officer and Executive Vice President.

Alere Inc. Declares Cash Dividend on Series B Convertible Perpetual Preferred Stock, Payable on October 15, 2015

Alere Inc. has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock. The dividend is payable on October 15, 2015 to holders of record of Series B stock at the close of business on October 1, 2015. Such payment will cover the amount of all dividends accrued from July 1, 2015 through September 30, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALR:US $46.93 USD -0.36

ALR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $139.20 USD +0.57
BioMerieux €93.80 EUR -0.63
PerkinElmer Inc $48.13 USD +0.25
STERIS Corp $66.55 USD -0.76
Teleflex Inc $125.24 USD +0.09
View Industry Companies

Industry Analysis


Industry Average

Valuation ALR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 2.7x
Price/Cash Flow 17.3x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALERE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at